Alphatec Holdings, Inc. (ATEC)
ATEC Stock Price Chart
Explore Alphatec Holdings, Inc. interactive price chart. Choose custom timeframes to analyze ATEC price movements and trends.
ATEC Company Profile
Discover essential business fundamentals and corporate details for Alphatec Holdings, Inc. (ATEC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
12 Jun 2006
Employees
867.00
Website
https://www.atecspine.comCEO
Patrick S. Miles
Description
Alphatec Holdings, Inc. is a medical technology firm dedicated to engineering and advancing solutions for the surgical management of spinal conditions. Its product array includes the Alpha InformatiX platform, notably the SafeOp Neural InformatiX System, which is engineered to reduce the likelihood of nerve injury during surgery. For access and positioning, Alphatec offers systems such as the Sigma transforaminal lumbar interbody fusion pedicle-based access system, the Sigma PTP Access and Patient Positioning System, and the Squadron lateral retractor, all designed to optimize surgical outcomes. The company's robust line of spinal fixation devices features the Invictus Spinal Fixation System, capable of addressing various thoracolumbar pathologies, alongside its minimally invasive SingleStep System and adaptable Modular Fixation Systems, which enhance screw modularity. Further fixation options include the OsseoScrew system for spinal column restoration and the comprehensive Arsenal spinal fixation platform, catering to a spectrum of degenerative to deformity procedures. Alphatec also provides anterior lumbar plating solutions like the Aspida Anterior Lumbar Plating System for interbody fusion and the AMP Anti-Migration Plate, in addition to cervical fixation options such as the OCT Spinal Fixation System, the Trestle Luxe Anterior Cervical Plate System, and the Insignia Anterior Cervical Plate System. Its portfolio extends to interbody implants, including IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Implants. A comprehensive suite of biologics is also available, featuring Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. The company additionally offers EOS imaging products. Alphatec Holdings markets its diverse product range throughout the United States via a network of independent distributors and its own direct sales force. Established in 1990, the company's headquarters are located in Carlsbad, California.
ATEC Financial Timeline
Browse a chronological timeline of Alphatec Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 Aug 2026
EPS estimate is $0.09, while revenue estimate is $211.26m.
Earnings released on 5 May 2026
EPS came in at -$0.22 falling short of the estimated -$0.01 by -2.10k%, while revenue for the quarter reached $192.11m , missing expectations by -2.74%.
Earnings released on 24 Feb 2026
EPS came in at $0.06 surpassing the estimated $0.04 by +50.00%, while revenue for the quarter reached $212.93m , beating expectations by +0.66%.
Earnings released on 30 Oct 2025
EPS came in at $0.03 surpassing the estimated -$0.03 by +200.00%, while revenue for the quarter reached $196.50m , missing expectations by -6.07%.
Earnings released on 31 Jul 2025
EPS came in at $0.02 surpassing the estimated -$0.06 by +133.33%, while revenue for the quarter reached $185.54m , beating expectations by +1.59%.
Earnings released on 1 May 2025
EPS came in at -$0.23 falling short of the estimated -$0.12 by -91.67%, while revenue for the quarter reached $169.18m , missing expectations by -5.41%.
Earnings released on 26 Feb 2025
EPS came in at -$0.23 falling short of the estimated -$0.19 by -21.05%, while revenue for the quarter reached $176.79m , beating expectations by +2.35%.
Earnings released on 30 Oct 2024
EPS came in at -$0.28 falling short of the estimated -$0.27 by -3.70%, while revenue for the quarter reached $150.72m , missing expectations by -11.50%.
Earnings released on 31 Jul 2024
EPS came in at -$0.29 falling short of the estimated -$0.26 by -11.54%, while revenue for the quarter reached $145.57m , missing expectations by -1.15%.
Earnings released on 7 May 2024
EPS came in at -$0.34 falling short of the estimated -$0.33 by -3.03%, while revenue for the quarter reached $138.48m , beating expectations by +3.31%.
Earnings released on 27 Feb 2024
EPS came in at -$0.37 falling short of the estimated -$0.28 by -32.14%, while revenue for the quarter reached $137.97m , beating expectations by +5.31%.
Earnings released on 6 Nov 2023
EPS came in at -$0.35 falling short of the estimated -$0.30 by -16.67%, while revenue for the quarter reached $118.26m , missing expectations by -7.74%.
Earnings released on 3 Aug 2023
EPS came in at -$0.43 falling short of the estimated -$0.30 by -43.33%, while revenue for the quarter reached $116.92m , beating expectations by +6.40%.
Earnings released on 4 May 2023
EPS came in at -$0.40 falling short of the estimated -$0.32 by -25.00%, while revenue for the quarter reached $109.11m , beating expectations by +4.21%.
Earnings released on 28 Feb 2023
EPS came in at -$0.33 falling short of the estimated -$0.30 by -10.00%, while revenue for the quarter reached $105.94m , beating expectations by +3.71%.
Earnings released on 3 Nov 2022
EPS came in at -$0.35 falling short of the estimated -$0.32 by -9.37%, while revenue for the quarter reached $89.84m , beating expectations by +8.32%.
Earnings released on 4 Aug 2022
EPS came in at -$0.36 falling short of the estimated -$0.35 by -2.86%, while revenue for the quarter reached $84.15m , beating expectations by +7.77%.
Earnings released on 5 May 2022
EPS came in at -$0.43 falling short of the estimated -$0.29 by -48.28%, while revenue for the quarter reached $70.93m , beating expectations by +7.29%.
Earnings released on 1 Mar 2022
EPS came in at -$0.40 falling short of the estimated -$0.31 by -29.03%, while revenue for the quarter reached $73.96m , beating expectations by +6.58%.
Earnings released on 4 Nov 2021
EPS came in at -$0.43 falling short of the estimated -$0.23 by -86.96%, while revenue for the quarter reached $62.88m , beating expectations by +37.67%.
Earnings released on 3 Aug 2021
EPS came in at -$0.30 falling short of the estimated -$0.20 by -50.00%, while revenue for the quarter reached $62.25m , beating expectations by +6.41%.
ATEC Stock Performance
Access detailed ATEC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
